Share it
One business bright spot of the coronavirus pandemic has been skyrocketing use of telehealth as patients stayed home and out of doctor offices, benefiting virtual care firms like Teladoc.
The boom has rippled out to makers of remote patient monitoring and wearables like continuous glucose monitors and insulin pumps, where devices are utilized to either deliver basic care or monitor patients and collect data. And while the explosion in use is likely to stabilize, experts say the healthcare landscape will be permanently changed post-pandemic.
Diabetes players Dexcom and Insulet both projected business growth and market expansion for this year during presentations at the J.P. Morgan healthcare conference.